Login / Signup
Effects of atrasentan on markers of liver function in patients with type 2 diabetes and chronic kidney disease.
Donald E Kohan
Adrian Liew
Sydney C W Tang
Jonathan Barratt
Hiddo J Lambers Heerspink
Published in:
Diabetes, obesity & metabolism (2023)
Keyphrases
</>
chronic kidney disease
end stage renal disease